Skip to main content
  • Home
  • Scheme Overview

Nippon India Pharma Fund - IDCW Option

(Erstwhile Reliance Pharma Fund-Dividend Plan)

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-06-2004
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 1.82% As on (30-04-2024)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 7,132.82 Cr As on (30-04-2024)
Turn over: 14
NAV (₹): 108.055
₹ 1.18 ( 1.0928%)
as on 10-05-2024
CAGR Since Inception - 19.9%
S&P BSE Healthcare TRI - 14.65%

Fund Managers

Sailesh Raj Bhan


Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

PERFORMANCE of Nippon India Pharma Fund - IDCW Option

Scheme Performance (%) Data as on - 10-05-2024

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Nippon India Pharma Fund - IDCW Option 47.39 13.06 22.84 15.77 19.9
S&P BSE Healthcare TRI 49.81 12.89 21.11 13.21 14.65
Equity: Sectoral-Pharma and Healthcare 47.31 13.23 23.25 15.24 17.65

RETURNS CALCULATOR for Nippon India Pharma Fund - IDCW Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of Nippon India Pharma Fund - IDCW Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Nippon India Pharma Fund - IDCW Option 15.77 0.32 1.92 0.97 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Nippon India Pharma Fund IDCW 05-06-2004 47.39 25.12 13.06 22.84 15.77
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum 25-07-2018 51.94 28.18 14.98 24.86 0.0
ABSL Pharma and Healthcare Reg Gr 05-07-2019 50.58 24.64 12.53 0.0 0.0
SBI HEALTHCARE Opportunities Reg Gr 14-07-1999 50.51 30.09 15.22 23.78 15.38
Nippon India Pharma Fund Gr Gr 01-06-2004 48.48 25.59 13.39 23.61 16.8
Tata India Pharma & Healthcare Reg Gr 28-12-2015 48.1 25.45 14.29 22.69 0.0
DSP Healthcare Reg Gr 05-11-2018 48.09 28.28 15.5 26.33 0.0
UTI Healthcare Reg Gr 05-08-2005 46.32 23.57 11.62 21.5 13.54
Mirae Asset Healthcare Reg Gr 10-07-2018 44.16 22.28 12.81 24.17 0.0
ITI Pharma and Healthcare Fund Reg Gr 08-11-2021 42.56 22.87 0.0 0.0 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of Nippon India Pharma Fund - IDCW Option

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)

AMC partners we work with